medicina60巻3号

2023年03月発行

特集 令和の脳卒中ディベート10番勝負—脳卒中治療ガイドライン2021とその先を識る ディベート・セクション　10番勝負 塞栓源不明の脳塞栓症（ESUS）の治療

Con　再発予防に抗凝固療法を考慮すべきESUSがある

著者： 片野雄大¹ 木村和美¹

所属機関： ¹日本医科大学脳神経内科

ページ範囲：P.523 - P.526

　塞栓源不明の脳塞栓症（embolic stroke of undetermined source：ESUS）の二次予防には抗凝固療法が有用である一群が存在する．本稿では，ESUSにおける抗凝固療法が適する患者群について考察する．

参考文献

1）Hart RG, et al：Embolic strokes of undetermined source；The case for a new clinical construct. Lancet Neurol 13：429-438, 2014

2）Hart RG, et al：Rivaroxaban for stroke prevention after embolic stroke of undetermined source. N Engl J Med 378：2191-2201, 2018

3）Diener HC, et al：Dabigatran for prevention of stroke after embolic stroke of undetermined source. N Engl J Med 380：1906-1917, 2019

4）Caplan LR：Intracranial branch atheromatous disease；A neglected, understudied, and underused concept. Neurology 39：1246-1250, 1989

5）Petrone L, et al：Branch atheromatous disease；A clinically meaningful, yet unproven concept. Cerebrovasc Dis 41：87-95, 2016

6）Uchiyama S, et al；NAVIGATE ESUS Investigators：Branch atheromatous disease diagnosed as embolic stroke of undetermined source；A subanalysis of NAVIGATE ESUS. Int J Stroke 14：915-922, 2019

7）Toyoda K, et al：Dabigatran vs. Aspirin for secondary prevention after embolic stroke of undetermined source- japanese subanalysis of the re-spect esus randomized controlled trial. Circ J 84：2286-2295, 2020

8）Coutinho JM, et al：Nonstenotic carotid plaque on CT angiography in patients with cryptogenic stroke. Neurology 87：665-672, 2016

9）Ueno Y, et al：Emerging risk factors for recurrent vascular events in patients with embolic stroke of undetermined source. Stroke 47：2714-2721, 2016

10）Caplan LR：Atrial fibrillation, past and future；From a stroke non-entity to an over-targeted cause. Cerebrovasc Dis 45：149-153, 2018

11）Kasner SE, et al；NAVIGATE ESUS Investigators：Rivaroxaban or aspirin for patent foramen ovale and embolic stroke of undetermined source；A prespecified subgroup analysis from the NAVIGATE ESUS trial. Lancet Neurol 17：1053-1060, 2018

12）Kamel H, et al：Tailoring the approach to embolic stroke of undetermined source；A review. JAMA Neurol 76：855-861, 2019

13）Guichard JB, et al：Atrial cardiomyopathy；A useful notion in cardiac disease management or a passing fad?. J Am Col Cardiol 70：756-765, 2017

14）Geisler T, et al： Apixaban for treatment of embolic stroke of undetermined source（ATTICUS randomized trial）；Rationale and design. Int J Stroke 12：985-990, 2017

15）Kamel H, et al：The atrial cardiopathy and antithrombotic drugs in prevention after cryptogenic stroke randomized trial；Rationale and methods. Int J Stroke 14：207-214, 2019